NASDAQ:ARWR

Arrowhead Research Stock News

etoro logo Buy ARWR
*Your capital is at risk
$82.00
+0.180 (+0.220%)
At Close: Jun 22, 2026
It hasn't been the best quarter for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) shareholders, since the share price...
Guggenheim Capital LLC increased its holdings in shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) by 847.3% during the 4th quarter, according to the company in its most recent 13F filing with the
While a vaccine for the virus may be many months away, existing innovations and technology are already helping scientists and pharmaceutical companies understan
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) Director Douglas B. Given sold 25,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 14th. The stock was sold at an avera
How this Week’s Premium Top 10 Performed, April 17, 2020 Posted by Greg Harmon on April 17th, 2020 Each week I post the performance of the stocks that were given to subscribers the previous Sunday.
Arrowhead Pharmaceuticals (NASDAQ:ARWR) was upgraded by investment analysts at Cantor Fitzgerald from a “neutral” rating to an “overweight” rating in a note issued to investors on Wednesday, M
Yesterday, a Director at Arrowhead Pharmaceuticals (ARWR – Research Report), Douglas Given, sold shares of ARWR for $922.3K. Following Douglas

's Top Upgrades, Downgrades For April 15, 2020

01:39pm, Wednesday, 15'th Apr 2020
Upgrades For Air Products & Chemicals Inc (NYSE: APD), Bernstein upgraded the stock from Market Perform to Outperform. For the first quarter, Air Products &...
Wednesday's top analyst upgrades and downgrades included Akamai Technologies, Carlyle, Ford, General Motors, JD.com, Moderna, Netflix, Peloton Interactive, Raytheon Technologies, Target, Tesla and Vis

2 Top Small-Cap Stocks to Buy Right Now

12:09pm, Wednesday, 15'th Apr 2020
These development-stage drug companies are well positioned for success, even amid the current market uncertainty.
By Salvatore Stolfo, PhD A crisis like the global COVID-19 pandemic can bring out the best in people. All over the world, we've witnessed acts of bravery and kindness from everyone from doctors a
Nuveen Asset Management LLC reduced its holdings in shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) by 5.6% during the fourth quarter, Holdings Channel reports. The fund owned 371,901 shares of
Ladenburg Thalmann Financial Services Inc. raised its holdings in Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) by 217.7% in the fourth quarter, according to its most recent 13F filing with the Securiti
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE